[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Neurostimulation Devices Market By Devices (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices) By Applications (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications) By Region, Industry Analysis and Forecast, 2020 - 2026

May 2020 | 205 pages | ID: GA5DCBA1CACCEN
KBV Research

US$ 3,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Neurostimulation Devices Market size is expected to reach $10.5 billion by 2026, rising at a market growth of 12.5% CAGR during the forecast period. Neuromodulation is a process that uses an implantable medical device to modulate and alter neural activity for therapeutic purposes. Neuromodulation equipment is called the neurostimulator that helps to treat neurological conditions that can provide an electric stimulus to the expected brain, nervous system, and spinal cord of the patient.

The central nervous systems (CNS) as well as the human peripheral nervous system (PNS) have affected neurological diseases such as Alzheimer's, Parkinson's, epilepsy, and cerebrovascular disease. The neurostimulation technique plays a vital role in the management of these neurological disorders. The electrodes in the devices generate mild electrical impulses to complement the neurological activity of the patients.

Among the many treatment options for overactive bladder symptoms is sacral nerve stimulation therapy (also known as sacral neuromodulation therapy). The treatment of overactive bladder with or without urine leakage and bladder vacuum can be done with sacral nerve stimulation therapy. In certain individuals who have not undergone more conservative treatments including drug therapy, the sacral nerve stimulation therapy is more suitable. Usually, a medication, behavioral therapy, and/or physical therapy must be completed before the sacral nerve stimulation therapy is taken into consideration.

Stimulation of the vagus nerve reduces seizures by transmitting normal, mild electrical energy through the vagus nerve into the brain. Often it is recognized as a 'brain pacemaker.' A pacemaker is inserted into the chest under the skin. The vagus nerve of the neck is wound around a cable from the device.

Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix, Abbott Laboratories, Medtronic PLC, and Boston Scientific Corporation are the forerunners in the Neurostimulation Devices Market. Companies such as LivaNova PLC, NeuroPace, Inc., Nevro Corporation, NeuroSigma, Inc., Neuronetics, Inc., Synapse Biomedical, Inc., and Integer Holdings Corporation are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.

Recent strategies deployed in Neurostimulation Devices Market

Partnerships, Collaborations, and Agreements:

May-2020: Medtronic collaborated with UW following which the company has accelerated research into deep brain stimulation treatment for essential tremor, Parkinson’s disease, and other neurological disorders.
Oct-2019: NeuroSigma came into partnership with Quick Care Pharmacy, a California-based specialty pharmacy. Following the partnership, the latter company was aimed to sell and distribute the former company's Monarch eTNS System (Monarch) for the treatment of pediatric ADHD in the United States.
Jun-2019: Neuronetics teamed up with Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business. Following the collaboration, Teijin sells NeuroStar Transcranial Magnetic Stimulation (TMS) in Japan.
May-2019: Abbott came into partnership with the US National Institutes of Health (NIH). The partnership was aimed at developing unique insights and driving the application of neurostimulation therapies. The partnership would provide the latter company's neuroscience research initiative BRAIN access to Abbott’s neuromodulation technologies.
Acquisition and Mergers:
Jan-2020: Medtronic took over Stimgenics, a startup company that has developed a novel spinal cord stimulation waveform. This acquisition enabled the company to expand its business in the SCS Market.
Jun-2019: Boston Scientific acquired Vertiflex, a healthcare company. Through this acquisition, Vertiflex's spinal cord stimulation and radiofrequency ablation have been added to Boston Scientific's product portfolio.
Jan-2018: LivaNova PLC acquired ImThera Medical, a company focused on neurostimulation for the treatment of obstructive sleep apnea (“OSA”). The acquisition strengthened its position as a leader in the field of neuromodulation.
Jul-2016: Boston took over Cosman Medical following which Cosman operates under the Boston Scientific Neuromodulation business. Following the acquisition, the company aimed to offer a wide range of spinal cord stimulator (SCS) systems to the patients suffering from chronic pain.
Product Launches and Product Expansions:
Jan-2019: Boston Scientific introduced the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) Systems. The systems feature the Vercise Cartesia Directional Lead. The systems have the technology that enables the physicians in controlling the range, shape, position, and direction of electrical stimulation to treat the symptoms of Parkinson's disease (PD) through highly-personalized therapy.
Jan-2019: Boston launched WaveWriter Spinal Cord Stimulator (SCS) System in Europe for providing the treatment of chronic pain to people in Europe.
Approvals:
Mar-2020: Symmetry, LivaNova's vagus nerve stimulation therapy for treatment-resistant depression, got CE Mark in Europe. Symmetry is a small implantable device designed for stimulating the vagus nerve to improve symptoms of depression and quality of life.
Mar-2020: Neuronetics announced that its NeuroStar Advanced Therapy System has been approved by the FDA. This system is used for the treatment of bipolar depression. The system uses transcranial magnetic stimulation (TMS), a noninvasive form of neuromodulation, to stimulate areas of the brain that are underactive in depression.
Mar-2020: NeuroPace received approval from FDA for MRI labeling. The approval was for its RNS systems that are programmed to help people living with seizures who don't respond to medication. RNS system is the world's only closed-loop brain-responsive neurostimulation system that helps to prevent seizures at their source. The system comprises of a neurostimulator, leads mounted at the seizure foci, a remote monitor that uploads data, as well as an RNS tablet and patient data system. The data systems help the physicians with viewing data over a secure website which can further be used for personalized therapies.
Jan-2020: Medtronic secured a CE Mark for its Percept PC neurostimulator. It is the only deep brain stimulation (DBS) system launched in the EU with BrainSense technology, which senses and records brain signals while delivering DBS therapy to people with neurological disorders such as Parkinson’s disease.
Jan-2020: Abbott Laboratories got approval from the US Food and Drug Administration (FDA) for its Infinity Deep Brain Stimulation (DBS) system. This system would be used in the treatment of Parkinson’s disease. The system would enable targeting a specific area of the brain known as the internal globus pallidus (GPi) for improving the symptoms of Parkinson’s disease not controlled by medication.
Nov-2019: Nevro Corporation received approval from the FDA for the Senza Omnia Spinal Cord Stimulation (SCS) System. The Omnia system has been designed for delivering Nevro's proprietary HF10 therapy in addition to all other available SCS frequencies.

Scope of the Study

Market Segmentation:

By Devices
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators and
  • Other Devices
By Applications
  • Pain Management
  • Hearing Loss
  • Urinary Incontinence
  • Parkinson's Disease
  • Epilepsy and
  • Other Applications
By Geography
  • North America
    • US
    • Canada
        • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA
Companies Profiled
  • Abbott Laboratories
  • Boston Scientific Corporation
      • Nevro Corporation
  • Medtronic PLC
  • NeuroSigma, Inc.
  • Integer Holdings Corporation
  • LivaNova PLC
  • NeuroPace, Inc.
  • Neuronetics, Inc.
  • Synapse BioMedical, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
  1.4.1 Global Neurostimulation Devices Market, by Devices
  1.4.2 Global Neurostimulation Devices Market, by Applications
  1.4.3 Global Neurostimulation Devices Market, by Geography
1.5 Methodology for the research

CHAPTER 2. MARKET OVERVIEW

2.1 Introduction
  2.1.1 Overview
  2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
  2.2.1 Market Drivers
  2.2.2 Market Restraints

CHAPTER 3. COMPETITION ANALYSIS - GLOBAL

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
  3.2.1 Partnerships, Collaborations and Agreements
  3.2.2 Product Launches and Product Expansions
  3.2.3 Mergers & Acquisitions
  3.2.4 Approvals
3.3 Top Winning Strategies
  3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
  3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players

CHAPTER 4. GLOBAL NEUROSTIMULATION DEVICES MARKET BY DEVICES

4.1 Global Spinal Cord Stimulators Market by Region
4.2 Global Deep Brain Stimulators Market by Region
4.3 Global Sacral Nerve Stimulators Market by Region
4.4 Global Vagus Nerve Stimulators Market by Region
4.5 Global Other Devices Market by Region

CHAPTER 5. GLOBAL NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS

5.1 Global Pain Management Market by Region
5.2 Global Hearing Loss Market by Region
5.3 Global Urinary Incontinence Market by Region
5.4 Global Parkinson's Disease Market by Region
5.5 Global Epilepsy Market by Region
5.6 Global Other Applications Market by Region

CHAPTER 6. GLOBAL NEUROSTIMULATION DEVICES MARKET BY REGION

6.1 North America Neurostimulation Devices Market
  6.1.1 North America Neurostimulation Devices Market by Devices
    6.1.1.1 North America Spinal Cord Stimulators Market by Country
    6.1.1.2 North America Deep Brain Stimulators Market by Country
    6.1.1.3 North America Sacral Nerve Stimulators Market by Country
    6.1.1.4 North America Vagus Nerve Stimulators Market by Country
    6.1.1.5 North America Other Devices Market by Country
  6.1.2 North America Neurostimulation Devices Market by Applications
    6.1.2.1 North America Pain Management Market by Country
    6.1.2.2 North America Hearing Loss Market by Country
    6.1.2.3 North America Urinary Incontinence Market by Country
    6.1.2.4 North America Parkinson's Disease Market by Country
    6.1.2.5 North America Epilepsy Market by Country
    6.1.2.6 North America Other Applications Market by Country
  6.1.3 North America Neurostimulation Devices Market by Country
    6.1.3.1 US Neurostimulation Devices Market
      6.1.3.1.1 US Neurostimulation Devices Market by Devices
      6.1.3.1.2 US Neurostimulation Devices Market by Applications
    6.1.3.2 Canada Neurostimulation Devices Market
      6.1.3.2.1 Canada Neurostimulation Devices Market by Devices
      6.1.3.2.2 Canada Neurostimulation Devices Market by Applications
    6.1.3.3 Mexico Neurostimulation Devices Market
      6.1.3.3.1 Mexico Neurostimulation Devices Market by Devices
      6.1.3.3.2 Mexico Neurostimulation Devices Market by Applications
    6.1.3.4 Rest of North America Neurostimulation Devices Market
      6.1.3.4.1 Rest of North America Neurostimulation Devices Market by Devices
      6.1.3.4.2 Rest of North America Neurostimulation Devices Market by Applications
6.2 Europe Neurostimulation Devices Market
  6.2.1 Europe Neurostimulation Devices Market by Devices
    6.2.1.1 Europe Spinal Cord Stimulators Market by Country
    6.2.1.2 Europe Deep Brain Stimulators Market by Country
    6.2.1.3 Europe Sacral Nerve Stimulators Market by Country
    6.2.1.4 Europe Vagus Nerve Stimulators Market by Country
    6.2.1.5 Europe Other Devices Market by Country
  6.2.2 Europe Neurostimulation Devices Market by Applications
    6.2.2.1 Europe Pain Management Market by Country
    6.2.2.2 Europe Hearing Loss Market by Country
    6.2.2.3 Europe Urinary Incontinence Market by Country
    6.2.2.4 Europe Parkinson's Disease Market by Country
    6.2.2.5 Europe Epilepsy Market by Country
    6.2.2.6 Europe Other Applications Market by Country
  6.2.3 Europe Neurostimulation Devices Market by Country
    6.2.3.1 Germany Neurostimulation Devices Market
      6.2.3.1.1 Germany Neurostimulation Devices Market by Devices
      6.2.3.1.2 Germany Neurostimulation Devices Market by Applications
    6.2.3.2 UK Neurostimulation Devices Market
      6.2.3.2.1 UK Neurostimulation Devices Market by Devices
      6.2.3.2.2 UK Neurostimulation Devices Market by Applications
    6.2.3.3 France Neurostimulation Devices Market
      6.2.3.3.1 France Neurostimulation Devices Market by Devices
      6.2.3.3.2 France Neurostimulation Devices Market by Applications
    6.2.3.4 Russia Neurostimulation Devices Market
      6.2.3.4.1 Russia Neurostimulation Devices Market by Devices
      6.2.3.4.2 Russia Neurostimulation Devices Market by Applications
    6.2.3.5 Spain Neurostimulation Devices Market
      6.2.3.5.1 Spain Neurostimulation Devices Market by Devices
      6.2.3.5.2 Spain Neurostimulation Devices Market by Applications
    6.2.3.6 Italy Neurostimulation Devices Market
      6.2.3.6.1 Italy Neurostimulation Devices Market by Devices
      6.2.3.6.2 Italy Neurostimulation Devices Market by Applications
    6.2.3.7 Rest of Europe Neurostimulation Devices Market
      6.2.3.7.1 Rest of Europe Neurostimulation Devices Market by Devices
      6.2.3.7.2 Rest of Europe Neurostimulation Devices Market by Applications
6.3 Asia Pacific Neurostimulation Devices Market
  6.3.1 Asia Pacific Neurostimulation Devices Market by Devices
    6.3.1.1 Asia Pacific Spinal Cord Stimulators Market by Country
    6.3.1.2 Asia Pacific Deep Brain Stimulators Market by Country
    6.3.1.3 Asia Pacific Sacral Nerve Stimulators Market by Country
    6.3.1.4 Asia Pacific Vagus Nerve Stimulators Market by Country
    6.3.1.5 Asia Pacific Other Devices Market by Country
  6.3.2 Asia Pacific Neurostimulation Devices Market by Applications
    6.3.2.1 Asia Pacific Pain Management Market by Country
    6.3.2.2 Asia Pacific Hearing Loss Market by Country
    6.3.2.3 Asia Pacific Urinary Incontinence Market by Country
    6.3.2.4 Asia Pacific Parkinson's Disease Market by Country
    6.3.2.5 Asia Pacific Epilepsy Market by Country
    6.3.2.6 Asia Pacific Other Applications Market by Country
  6.3.3 Asia Pacific Neurostimulation Devices Market by Country
    6.3.3.1 China Neurostimulation Devices Market
      6.3.3.1.1 China Neurostimulation Devices Market by Devices
      6.3.3.1.2 China Neurostimulation Devices Market by Applications
    6.3.3.2 India Neurostimulation Devices Market
      6.3.3.2.1 India Neurostimulation Devices Market by Devices
      6.3.3.2.2 India Neurostimulation Devices Market by Applications
    6.3.3.3 Japan Neurostimulation Devices Market
      6.3.3.3.1 Japan Neurostimulation Devices Market by Devices
      6.3.3.3.2 Japan Neurostimulation Devices Market by Applications
    6.3.3.4 South Korea Neurostimulation Devices Market
      6.3.3.4.1 South Korea Neurostimulation Devices Market by Devices
      6.3.3.4.2 South Korea Neurostimulation Devices Market by Applications
    6.3.3.5 Singapore Neurostimulation Devices Market
      6.3.3.5.1 Singapore Neurostimulation Devices Market by Devices
      6.3.3.5.2 Singapore Neurostimulation Devices Market by Applications
    6.3.3.6 Malaysia Neurostimulation Devices Market
      6.3.3.6.1 Malaysia Neurostimulation Devices Market by Devices
      6.3.3.6.2 Malaysia Neurostimulation Devices Market by Applications
    6.3.3.7 Rest of Asia Pacific Neurostimulation Devices Market
      6.3.3.7.1 Rest of Asia Pacific Neurostimulation Devices Market by Devices
      6.3.3.7.2 Rest of Asia Pacific Neurostimulation Devices Market by Applications
6.4 LAMEA Neurostimulation Devices Market
  6.4.1 LAMEA Neurostimulation Devices Market by Devices
    6.4.1.1 LAMEA Spinal Cord Stimulators Market by Country
    6.4.1.2 LAMEA Deep Brain Stimulators Market by Country
    6.4.1.3 LAMEA Sacral Nerve Stimulators Market by Country
    6.4.1.4 LAMEA Vagus Nerve Stimulators Market by Country
    6.4.1.5 LAMEA Other Devices Market by Country
  6.4.2 LAMEA Neurostimulation Devices Market by Applications
    6.4.2.1 LAMEA Pain Management Market by Country
    6.4.2.2 LAMEA Hearing Loss Market by Country
    6.4.2.3 LAMEA Urinary Incontinence Market by Country
    6.4.2.4 LAMEA Parkinson's Disease Market by Country
    6.4.2.5 LAMEA Epilepsy Market by Country
    6.4.2.6 LAMEA Other Applications Market by Country
  6.4.3 LAMEA Neurostimulation Devices Market by Country
    6.4.3.1 Brazil Neurostimulation Devices Market
      6.4.3.1.1 Brazil Neurostimulation Devices Market by Devices
      6.4.3.1.2 Brazil Neurostimulation Devices Market by Applications
    6.4.3.2 Argentina Neurostimulation Devices Market
      6.4.3.2.1 Argentina Neurostimulation Devices Market by Devices
      6.4.3.2.2 Argentina Neurostimulation Devices Market by Applications
    6.4.3.3 UAE Neurostimulation Devices Market
      6.4.3.3.1 UAE Neurostimulation Devices Market by Devices
      6.4.3.3.2 UAE Neurostimulation Devices Market by Applications
    6.4.3.4 Saudi Arabia Neurostimulation Devices Market
      6.4.3.4.1 Saudi Arabia Neurostimulation Devices Market by Devices
      6.4.3.4.2 Saudi Arabia Neurostimulation Devices Market by Applications
    6.4.3.5 South Africa Neurostimulation Devices Market
      6.4.3.5.1 South Africa Neurostimulation Devices Market by Devices
      6.4.3.5.2 South Africa Neurostimulation Devices Market by Applications
    6.4.3.6 Nigeria Neurostimulation Devices Market
      6.4.3.6.1 Nigeria Neurostimulation Devices Market by Devices
      6.4.3.6.2 Nigeria Neurostimulation Devices Market by Applications
    6.4.3.7 Rest of LAMEA Neurostimulation Devices Market
      6.4.3.7.1 Rest of LAMEA Neurostimulation Devices Market by Devices
      6.4.3.7.2 Rest of LAMEA Neurostimulation Devices Market by Applications

CHAPTER 7. COMPANY PROFILES

7.1 Abbott Laboratories
  7.1.1 Company Overview
  7.1.2 Financial Analysis
  7.1.3 Segmental and Regional Analysis
  7.1.4 Research & Development Expense
  7.1.5 Recent strategies and developments:
    7.1.5.1 Partnerships, Collaborations, and Agreements:
    7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
  7.2.1 Company Overview
  7.2.2 Financial Analysis
  7.2.3 Segmental and Regional Analysis
  7.2.4 Research & Development Expense
  7.2.5 Recent strategies and developments:
    7.2.5.1 Acquisition and Mergers:
    7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
  7.3.1 Company Overview
  7.3.2 Financial Analysis
  7.3.3 Regional Analysis
  7.3.4 Research & Development Expense
  7.3.5 Recent strategies and developments:
    7.3.5.1 Approvals:
7.4 Medtronic PLC
  7.4.1 Company overview
  7.4.2 Financial Analysis
  7.4.3 Segmental and Regional Analysis
  7.4.4 Research & Development Expenses
  7.4.5 Recent strategies and developments:
    7.4.5.1 Partnerships, Collaborations, and Agreements:
    7.4.5.2 Acquisition and Mergers:
    7.4.5.3 Product Launches and Product Expansions:
    7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
  7.5.1 Company Overview
  7.5.2 Recent strategies and developments:
    7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
  7.6.1 Company Overview
  7.6.2 Financial Analysis
  7.6.3 Segmental and Regional Analysis
  7.6.4 Research & Development Expense
7.7 LivaNova PLC
  7.7.1 Company Overview
  7.7.2 Financial Analysis
  7.7.3 Segmental and Regional Analysis
  7.7.4 Research & Development Expense
  7.7.5 Recent strategies and developments:
    7.7.5.1 Approvals:
    7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
  7.8.1 Company Overview
  7.8.2 Recent strategies and developments:
    7.8.2.1 Approvals:
    7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
  7.9.1 Company Overview
  7.9.2 Financial Analysis
  7.9.3 Regional Analysis
  7.9.4 Research & Development Expense
  7.9.5 Recent strategies and developments:
    7.9.5.1 Partnerships, Collaborations, and Agreements:
    7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
  7.10.1 Company Overview
  7.10.2 Recent strategies and developments:
    7.10.2.1 Approvals:

LIST OF TABLES

TABLE 1 GLOBAL NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 GLOBAL NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEUROSTIMULATION DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– NEUROSTIMULATION DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEUROSTIMULATION DEVICES MARKET
TABLE 6 APPROVALS – NEUROSTIMULATION DEVICES MARKET
TABLE 7 GLOBAL NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 8 GLOBAL NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 9 GLOBAL SPINAL CORD STIMULATORS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 10 GLOBAL SPINAL CORD STIMULATORS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 11 GLOBAL DEEP BRAIN STIMULATORS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 12 GLOBAL DEEP BRAIN STIMULATORS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 13 GLOBAL SACRAL NERVE STIMULATORS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 14 GLOBAL SACRAL NERVE STIMULATORS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 15 GLOBAL VAGUS NERVE STIMULATORS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 16 GLOBAL VAGUS NERVE STIMULATORS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 17 GLOBAL OTHER DEVICES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 18 GLOBAL OTHER DEVICES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 19 GLOBAL NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 20 GLOBAL NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 21 GLOBAL PAIN MANAGEMENT MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 22 GLOBAL PAIN MANAGEMENT MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 23 GLOBAL HEARING LOSS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 24 GLOBAL HEARING LOSS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 25 GLOBAL URINARY INCONTINENCE MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 26 GLOBAL URINARY INCONTINENCE MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 27 GLOBAL PARKINSON'S DISEASE MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 28 GLOBAL PARKINSON'S DISEASE MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 29 GLOBAL EPILEPSY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 30 GLOBAL EPILEPSY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 31 GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 32 GLOBAL OTHER APPLICATIONS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 33 GLOBAL NEUROSTIMULATION DEVICES MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 34 GLOBAL NEUROSTIMULATION DEVICES MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 35 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 38 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 39 NORTH AMERICA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 40 NORTH AMERICA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 41 NORTH AMERICA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 42 NORTH AMERICA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 43 NORTH AMERICA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 44 NORTH AMERICA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 45 NORTH AMERICA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 46 NORTH AMERICA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 47 NORTH AMERICA OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 48 NORTH AMERICA OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 49 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 50 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 51 NORTH AMERICA PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 52 NORTH AMERICA PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 53 NORTH AMERICA HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 54 NORTH AMERICA HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 55 NORTH AMERICA URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 56 NORTH AMERICA URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 57 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 58 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 59 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 60 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 61 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 62 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 63 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 64 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 65 US NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 US NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 US NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 68 US NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 69 US NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 70 US NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 71 CANADA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 72 CANADA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 73 CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 74 CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 75 CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 76 CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 77 MEXICO NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 78 MEXICO NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 79 MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 80 MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 81 MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 82 MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 83 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 84 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 85 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 86 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 87 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 88 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 89 EUROPE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 90 EUROPE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 91 EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 92 EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 93 EUROPE SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 94 EUROPE SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 95 EUROPE DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 96 EUROPE DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 97 EUROPE SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 98 EUROPE SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 99 EUROPE VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 100 EUROPE VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 101 EUROPE OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 102 EUROPE OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 103 EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 104 EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 105 EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 106 EUROPE PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 107 EUROPE HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 108 EUROPE HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 109 EUROPE URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 110 EUROPE URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 111 EUROPE PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 112 EUROPE PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 113 EUROPE EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 114 EUROPE EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 115 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 116 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 117 EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 118 EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 119 GERMANY NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 120 GERMANY NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 121 GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 122 GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 123 GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 124 GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 125 UK NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 126 UK NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 127 UK NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 128 UK NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 129 UK NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 130 UK NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 131 FRANCE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 132 FRANCE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 133 FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 134 FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 135 FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 136 FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 137 RUSSIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 138 RUSSIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 139 RUSSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 140 RUSSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 141 RUSSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 142 RUSSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 143 SPAIN NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 144 SPAIN NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 145 SPAIN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 146 SPAIN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 147 SPAIN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 148 SPAIN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 149 ITALY NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 150 ITALY NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 151 ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 152 ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 153 ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 154 ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 155 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 156 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 157 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 158 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 159 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 160 REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 161 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 162 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 163 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 164 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 165 ASIA PACIFIC SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 166 ASIA PACIFIC SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 167 ASIA PACIFIC DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 168 ASIA PACIFIC DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 169 ASIA PACIFIC SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 170 ASIA PACIFIC SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 171 ASIA PACIFIC VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 172 ASIA PACIFIC VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 173 ASIA PACIFIC OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 174 ASIA PACIFIC OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 175 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 176 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 177 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 178 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 179 ASIA PACIFIC HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 180 ASIA PACIFIC HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 181 ASIA PACIFIC URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 182 ASIA PACIFIC URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 183 ASIA PACIFIC PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 184 ASIA PACIFIC PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 185 ASIA PACIFIC EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 186 ASIA PACIFIC EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 187 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 188 ASIA PACIFIC OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 189 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 190 ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 191 CHINA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 192 CHINA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 193 CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 194 CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 195 CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 196 CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 197 INDIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 198 INDIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 199 INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 200 INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 201 INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 202 INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 203 JAPAN NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 204 JAPAN NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 205 JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 206 JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 207 JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 208 JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 209 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 210 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 211 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 212 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 213 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 214 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 215 SINGAPORE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 216 SINGAPORE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 217 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 218 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 219 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 220 SINGAPORE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 221 MALAYSIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 222 MALAYSIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 223 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 224 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 225 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 226 MALAYSIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 227 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 228 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 229 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 230 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 231 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 232 REST OF ASIA PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 233 LAMEA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 234 LAMEA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 235 LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 236 LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 237 LAMEA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 238 LAMEA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 239 LAMEA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 240 LAMEA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 241 LAMEA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 242 LAMEA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 243 LAMEA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 244 LAMEA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 245 LAMEA OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 246 LAMEA OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 247 LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 248 LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 249 LAMEA PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 250 LAMEA PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 251 LAMEA HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 252 LAMEA HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 253 LAMEA URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 254 LAMEA URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 255 LAMEA PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 256 LAMEA PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 257 LAMEA EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 258 LAMEA EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 259 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 260 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 261 LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 262 LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 263 BRAZIL NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 264 BRAZIL NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 265 BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 266 BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 267 BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 268 BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 269 ARGENTINA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 270 ARGENTINA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 271 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 272 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 273 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 274 ARGENTINA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 275 UAE NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 276 UAE NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 277 UAE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 278 UAE NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 279 UAE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 280 UAE NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 281 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 282 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 283 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 284 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 285 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 286 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 287 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 288 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 289 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 290 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 291 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 292 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 293 NIGERIA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 294 NIGERIA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 295 NIGERIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 296 NIGERIA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 297 NIGERIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 298 NIGERIA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 299 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 300 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 301 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 302 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 303 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 304 REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 305 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 306 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 307 KEY INFORMATION – NEVRO CORPORATION
TABLE 308 KEY INFORMATION – MEDTRONIC PLC
TABLE 309 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 310 KEY INFORMATION – INTEGER HOLDINGS CORPORATION
TABLE 311 KEY INFORMATION – LIVANOVA PLC
TABLE 312 KEY INFORMATION – NEUROPACE, INC.
TABLE 313 KEY INFORMATION – NEURONETICS, INC.
TABLE 314 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: LIVANOVA PLC
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NEUROPACE, INC.

More Publications

Need Help?

Ask a Question

Market Reports

All Categories